[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003216501A8 - Methods of treating pin1 associated disorders - Google Patents

Methods of treating pin1 associated disorders

Info

Publication number
AU2003216501A8
AU2003216501A8 AU2003216501A AU2003216501A AU2003216501A8 AU 2003216501 A8 AU2003216501 A8 AU 2003216501A8 AU 2003216501 A AU2003216501 A AU 2003216501A AU 2003216501 A AU2003216501 A AU 2003216501A AU 2003216501 A8 AU2003216501 A8 AU 2003216501A8
Authority
AU
Australia
Prior art keywords
treating
methods
associated disorders
pin1 associated
pin1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003216501A
Other versions
AU2003216501A1 (en
Inventor
Janusz Sowadski
Robert K Suto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pintex Pharmaceuticals Inc
Original Assignee
Pintex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pintex Pharmaceuticals Inc filed Critical Pintex Pharmaceuticals Inc
Publication of AU2003216501A1 publication Critical patent/AU2003216501A1/en
Publication of AU2003216501A8 publication Critical patent/AU2003216501A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/552Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003216501A 2002-03-01 2003-03-03 Methods of treating pin1 associated disorders Abandoned AU2003216501A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36079902P 2002-03-01 2002-03-01
US60/360,799 2002-03-01
PCT/US2003/006518 WO2003074002A2 (en) 2002-03-01 2003-03-03 Methods of treating pin1 associated disorders

Publications (2)

Publication Number Publication Date
AU2003216501A1 AU2003216501A1 (en) 2003-09-16
AU2003216501A8 true AU2003216501A8 (en) 2003-09-16

Family

ID=27789027

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003216501A Abandoned AU2003216501A1 (en) 2002-03-01 2003-03-03 Methods of treating pin1 associated disorders

Country Status (2)

Country Link
AU (1) AU2003216501A1 (en)
WO (1) WO2003074002A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972697A (en) * 1995-11-13 1999-10-26 The Salk Institute For Biological Studies NIMA interacting proteins

Also Published As

Publication number Publication date
AU2003216501A1 (en) 2003-09-16
WO2003074002A3 (en) 2003-12-04
WO2003074002A2 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
IL208191A0 (en) Compositions and methods for treating rage-associated disorders
AU2003239489A8 (en) Method of treating dyslipidemic disorders
AU2003286567A8 (en) Methods for the treatment of skin disorders
PL372425A1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
PL373002A1 (en) Methods of treating ileus
IL164352A0 (en) Methods for treating tweak-related conditions
HK1203216A1 (en) Materials and methods for treating disorders of the ear
EP1476147A4 (en) Methods for treating eye disorders
EP1567198A4 (en) Materials and methods for treating ocular-related disorders
AU2003270536A1 (en) Method of treating skin disorders
IL163993A0 (en) Method for treating cognitive disorders
IL162053A0 (en) Method for the treatment of bone disorders
GB0208897D0 (en) New method of treatment
GB0217493D0 (en) Novel methods of treatment
AU2003216501A8 (en) Methods of treating pin1 associated disorders
EP1425020A4 (en) Methods and compositions for treating apoptosis associated disorders
GB0221712D0 (en) Methods of treatment
AU2003202255A8 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
AU2003297259A8 (en) Methods and compositions for treating neurological disorders
IL161630A0 (en) Methods of treating endometreosis
GB0216097D0 (en) Treatment of proliferative disorders
AU2003228813A8 (en) Methods for treating neuronal disorders
GB0213198D0 (en) Method of treatment
IL142102A0 (en) Zinc-sensing receptor and methods of treatment of disorders associated herewith
GB0207091D0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase